Lawmakers propose pathway to allow Medicare to cover weight-loss drugs

The US House Ways and Means Committee has proposed a strategy for Medicare to cover GLP-1 weight-loss drugs like Novo Nordisk's (NVO) Wegovy and Eli Lily's (LLY) Zepbound.
Yahoo Finance Health Reporter Anjalee Khemlani breaks down the details of the proposed bill ahead of Thursday's vote to amend part of the Treat and Reduce Obesity Act of 2023.
About Yahoo Finance:
Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
Get the latest news and data at finance.yahoo.com
Download the Yahoo Finance app on Apple (apple.co/3Rten0R) or Android (bit.ly/3t8UnXO)
Follow Yahoo Finance on social:
X: / yahoofinance
Instagram: www.instagram....
TikTok: www.tiktok.com...
Facebook: / yahoofinance
LinkedIn: / yahoo-finance
#ozempic #weightloss #yahoofinance